bluebird bio Announces First Patient Transplanted in Phase 1/2...

"We believe gene therapy represents a potentially new and exciting treatment option for patients with severe forms of beta-thalassemia and sickle cell disease" "We believe gene therapy represents a potentially new and exciting treatment option for patients with severe forms of beta-thalassemia and sickle cell disease," stated Marina Cavazzana, MD, ... (more)

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131202005276&newsLang=en&ndmConfigId=1000639&vnsId=41